Efficacy of EGFR-TKI sequential therapy in patients with EGFR exon 19 insertion-positive non-small-cell lung cancer: A case report

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 6

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

217

WORD

HTML

2469

Figures (1-2)

305

Sum=3061

Publishing Process of This Article

Item

Count

Browse

349

Download

1021

Sum=1370

Feb 26, 2022 (publication date) through Jan 14, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Feb 26, 2022; 10(6): 1883-1888
Published online Feb 26, 2022. doi: 10.12998/wjcc.v10.i6.1883

Full Size Figure Download Figure

Figure 2 Next-generation sequencing showed EGFR exon 19 insertion.

Citation: Shan BB, Li Y, Zhao C, An XQ, Zhang QM. Efficacy of EGFR-TKI sequential therapy in patients with EGFR exon 19 insertion-positive non-small-cell lung cancer: A case report. World J Clin Cases 2022; 10(6): 1883-1888
URL: https://www.wjgnet.com/2307-8960/full/v10/i6/1883.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i6.1883